All Phenotypes Irak4<tm1Lix> MGI Mouse

• 7-fold to 20-fold less found in serum 2 hours after dosing with LPS, CpG, or IL-1

• 5-fold to 100-fold less found in serum 2 hours after dosing with LPS, CpG, or IL-1

abnormal chemokine secretion ( J:125732 )

• reduced production by plasmacytoid DCs in response to ligands for TLR-7 and -9

• reduced production of IFN-alpha by macrophages in response to ligands for TLR-7 and -9

• reduced production of IFN-alpha by dendritic cells in response to influenza virus

• reduced production of IFN-beta by macrophages in response to ligands for TLR-7 and -9

• reduced production of IFN-beta by dendritic cells in response to influenza virus

decreased interleukin-6 secretion ( J:125732 )

• reduced production by macrophages in response to TLR ligands except for a ligand to TLR3

• reduced production of IFN-alpha and IFN-beta by dendritic cells in response to influenza virus

• reduced production by macrophages in response to TLR ligands except for a ligand to TLR3

• reduced production of IFN-alpha and IFN-beta by dendritic cells in response to influenza virus

decreased acute inflammation ( J:125732 )

• resistant to LPS- and CpG- induced shock

• no lethality when injected with a high dose of LPS or CpG

• 7-fold to 20-fold less found in serum 2 hours after dosing with LPS, CpG, or IL-1

• 5-fold to 100-fold less found in serum 2 hours after dosing with LPS, CpG, or IL-1

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 05/07/2024 MGI 6.23